Acumen Pharmaceuticals, Inc. (ABOS) NASDAQ

Currency In USD

Acumen Pharmaceuticals, Inc.

Address

1210-1220 Washington St.

Newton, MA 02465

United States of America (the)

Phone

434 297 1000

Website

https://acumenpharm.com

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

July 01, 2021

Key Executives

Name	Title	Pay	Year Born
Daniel J. O'Connell	Chief Executive Officer & Director	972,747	1970
William L. Klein	Co-Founder	42,000	N/A
Grant A. Krafft	Co-Founder	42,000	N/A
Caleb E. Finch	Co-Founder	42,000	N/A
Russell Barton	Chief Operating Officer	223,680	1959
Matt Zuga	Chief Financial Officer & Chief Business Officer	681,780	N/A
Derek Meisner	Chief Legal Officer & Corporate Secretary	752,945	1971
James Doherty	President & Chief Development Officer	764,370	1968
Alex Braun	Vice President & Head of Investor Relations	0	N/A
Kelly Carranza	Senior Vice President of Finance & Accounting and Corporate Controller	0	N/A

Description

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.